Literature DB >> 15610735

A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer.

Robert X Xu1, Millard H Lambert, Bruce B Wisely, Erin N Warren, Emily E Weinert, Gregory M Waitt, Jon D Williams, Jon L Collins, Linda B Moore, Timothy M Willson, John T Moore.   

Abstract

The X-ray crystal structure of the human constitutive androstane receptor (CAR, NR1I3)/retinoid X receptor alpha (RXRalpha, NR2B1) heterodimer sheds light on the mechanism of ligand-independent activation of transcription by nuclear receptors. CAR contains a single-turn Helix X that restricts the conformational freedom of the C-terminal AF2 helix, favoring the active state of the receptor. Helix X and AF2 sit atop four amino acids that shield the CAR ligand binding pocket. A fatty acid ligand was identified in the RXRalpha binding pocket. The endogenous RXRalpha ligand, combined with stabilizing interactions from the heterodimer interface, served to hold RXRalpha in an active conformation. The structure suggests that upon translocation, CAR/RXRalpha heterodimers are preorganized in an active conformation in cells such that they can regulate transcription of target genes. Insights into the molecular basis of CAR constitutive activity can be exploited in the design of inverse agonists as drugs for treatment of obesity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15610735     DOI: 10.1016/j.molcel.2004.11.042

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  76 in total

1.  Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation.

Authors:  Ryota Shizu; Makoto Osabe; Lalith Perera; Rick Moore; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

Review 2.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

4.  Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.

Authors:  Ann M Dring; Linnea E Anderson; Saima Qamar; Matthew A Stoner
Journal:  Chem Biol Interact       Date:  2010-10-20       Impact factor: 5.192

Review 5.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

6.  Development of CINPA1 analogs as novel and potent inverse agonists of constitutive androstane receptor.

Authors:  Wenwei Lin; Lei Yang; Sergio C Chai; Yan Lu; Taosheng Chen
Journal:  Eur J Med Chem       Date:  2015-12-15       Impact factor: 6.514

7.  Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.

Authors:  Edward Wright; Jeremy Vincent; Elias J Fernandez
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

8.  Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism.

Authors:  Li Shan; Jeremy Vincent; Joseph S Brunzelle; Isabelle Dussault; Min Lin; Irina Ianculescu; Mark A Sherman; Barry M Forman; Elias J Fernandez
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

Review 9.  A current structural perspective on PXR and CAR in drug metabolism.

Authors:  Cameron D Buchman; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-05-30       Impact factor: 4.481

10.  The HR97 (NR1L) group of nuclear receptors: a new group of nuclear receptors discovered in Daphnia species.

Authors:  Yangchun Li; Gautam K Ginjupalli; William S Baldwin
Journal:  Gen Comp Endocrinol       Date:  2014-08-01       Impact factor: 2.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.